The effects of alendronate in the treatment of experimental osteonecrosis of the hip in adult rabbits

Osteoarthritis and Cartilage

Volumn 17, Issue 3, 2009, Pages 362-370

  Hofstaetter, J G ^a,b   Wang, J ^a,c   Yan, J ^a   Glimcher, M J ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b UNIVERSITY OF VIENNA   (Austria)

^c UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

Alendronate; Femoral head; Micro computed tomography; Osteoarthritis; Osteonecrosis

Indexed keywords

ALENDRONIC ACID; PLACEBO;

ACETABULUM; ANIMAL EUTHANASIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DENSITY; CARTILAGE DEGENERATION; CONTROLLED STUDY; CORTICAL BONE; DRUG EFFICACY; EXPERIMENTAL MODEL; FEMUR HEAD NECROSIS; HIP OSTEOARTHRITIS; HISTOPATHOLOGY; MALE; MICRO-COMPUTED TOMOGRAPHY; NEW ZEALAND; NONHUMAN; POROSITY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RABBIT; RANDOMIZATION; SCORING SYSTEM; TRABECULAR BONE;

ACETABULUM; ADULT; ALENDRONATE; ANIMALS; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; BONE REMODELING; CONE-BEAM COMPUTED TOMOGRAPHY; DISEASE MODELS, ANIMAL; FEMUR HEAD NECROSIS; HUMANS; MALE; MICRORADIOGRAPHY; RABBITS; RANDOM ALLOCATION;

EID: 60249093860     PISSN: 10634584     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joca.2008.07.013     Document Type: Article

References (48)

1. Mankin H.J. Nontraumatic necrosis of bone (osteonecrosis). N Engl J Med 326 22 (1992) 1473-1479
2. Hungerford D.S., and Jones L.C. Asymptomatic osteonecrosis: should it be treated?. Clin Orthop 429 (2004) 124-130
3. Assouline-Dayan Y., Chang C., Greenspan A., Shoenfeld Y., and Gershwin M.E. Pathogenesis and natural history of osteonecrosis. Semin Arthritis Rheum 32 2 (2002) 94-124
4. Hernigou P., Poignard A., Nogier A., and Manicom O. Fate of very small asymptomatic stage-I osteonecrotic lesions of the hip. J Bone Joint Surg Am 86-A 12 (2004) 2589-2593
5. Marciniak D., Furey C., and Shaffer J.W. Osteonecrosis of the femoral head. A study of 101 hips treated with vascularized fibular grafting. J Bone Joint Surg Am 87-A 4 (2005) 742-747
6. Beaule P.E., and Amstutz H.C. Management of Ficat stage III and IV osteonecrosis of the hip. J Am Acad Orthop Surg 12 2 (2004) 96-105
7. Hungerford D.S. Treatment of osteonecrosis of the femoral head: everything's new. J Arthroplasty 22 4 Suppl 1 (2007) 91-94
8. Petrigliano F.A., and Lieberman J.R. Osteonecrosis of the hip: novel approaches to evaluation and treatment. Clin Orthop Relat Res 465 (2007) 53-62
9. Hartley W.T., McAuley J.P., Culpepper W.J., Engh Jr. C.A., and Engh Sr. C.A. Osteonecrosis of the femoral head treated with cementless total hip arthroplasty. J Bone Joint Surg Am 82-A 10 (2000) 1408-1413
10. Fratzl P., Gupta H.S., Paschalis E.P., and Roschger P. Structure and mechanical quality of the collagen-mineral nano-composite in bone. J Mater Chem 14 (2004) 2115-2123
11. Glimcher M.J. Cell biology during repair of osteonecrosis: implications for rational treatment. Acta Orthop Belg 65 Suppl 1 (1999) 17-22
12. Glimcher M.J., and Kenzora J.E. The biology of osteonecrosis of the human femoral head and its clinical implications: II. The pathological changes in the femoral head as an organ and in the hip joint. Clin Orthop 139 (1979) 283-312
13. Glimcher M.J., and Kenzora J.E. The biology of osteonecrosis of the human femoral head and its clinical implications. III. Discussion of the etiology and genesis of the pathological sequelae; commments on treatment. Clin Orthop 140 (1979) 273-312
14. Hofstaetter J.G., Wang J., Yan J., and Glimcher M.J. Changes in bone microarchitecture and bone mineral density following experimental osteonecrosis of the hip in rabbits. Cells Tissues Organs 184 3-4 (2006) 138-147
15. Rodan G., Reszka A., Golub E., and Rizzoli R. Bone safety of long-term bisphosphonate treatment. Curr Med Res Opin 20 8 (2004) 1291-1300
16. Astrand J., and Aspenberg P. Systemic alendronate prevents resorption of necrotic bone during revascularization. A bone chamber study in rats. BMC Musculoskelet Disord 3 1 (2002) 19
17. Kim H.K., Randall T.S., Bian H., Jenkins J., Garces A., and Bauss F. Ibandronate for prevention of femoral head deformity after ischemic necrosis of the capital femoral epiphysis in immature pigs. J Bone Joint Surg Am 87-A 3 (2005) 550-557
18. Little D.G., Peat R.A., McEvoy A., Williams P.R., Smith E.J., and Baldock P.A. Zoledronic acid treatment results in retention of femoral head structure after traumatic osteonecrosis in young Wistar rats. J Bone Miner Res 18 11 (2003) 2016-2022
19. Ramachandran M., Ward K., Brown R.R., Munns C.F., Cowell C.T., and Little D.G. Intravenous bisphosphonate therapy for traumatic osteonecrosis of the femoral head in adolescents. J Bone Joint Surg Am 89 8 (2007) 1727-1734
20. Agarwala S., Jain D., Joshi V.R., and Sule A. Efficacy of alendronate, a bisphosphonate, in the treatment of AVN of the hip. A prospective open-label study. Rheumatology (Oxford) 44 3 (2005) 352-359
21. Lai K.A., Shen W.J., Yang C.Y., Shao C.J., Hsu J.T., and Lin R.M. The use of alendronate to prevent early collapse of the femoral head in patients with nontraumatic osteonecrosis. A randomized clinical study. J Bone Joint Surg Am 87 10 (2005) 2155-2159
22. Nishii T., Sugano N., Miki H., Hashimoto J., and Yoshikawa H. Does alendronate prevent collapse in osteonecrosis of the femoral head?. Clin Orthop Relat Res 443 (2006) 273-279
23. McCreadie B.R., Goulet R.W., Feldkamp L.A., and Goldstein S.A. Hierarchical structure of bone and micro-computed tomography. Adv Exp Med Biol 496 (2001) 67-83
24. Barou O., Valentin D., Vico L., Tirode C., Barbier A., Alexandre C., et al. High-resolution three-dimensional micro-computed tomography detects bone loss and changes in trabecular architecture early: comparison with DEXA and bone histomorphometry in a rat model of disuse osteoporosis. Invest Radiol 37 1 (2002) 40-46
25. Ding M., Odgaard A., and Hvid I. Changes in the three-dimensional microstructure of human tibial cancellous bone in early osteoarthritis. J Bone Joint Surg Br 85 6 (2003) 906-912
26. Batiste D.L., Kirkley A., Laverty S., Thain L.M., Spouge A.R., Gati J.S., et al. High-resolution MRI and micro-CT in an ex vivo rabbit anterior cruciate ligament transection model of osteoarthritis. Osteoarthritis Cartilage 12 8 (2004) 614-626
27. Wachsmuth L., and Engelke K. High-resolution imaging of osteoarthritis using microcomputed tomography. Methods Mol Med 101 (2004) 231-248
28. Otsu N. A threshold selection method from gray-level histograms. IEEE Trans Syst Man Cybern 9 (1979) 62-66
29. Mankin H.J., Dorfman H., Lippiello L., and Zarins A. Biochemical and metabolic abnormalities in articular cartilage from osteo-arthritic human hips. II. Correlation of morphology with biochemical and metabolic data. J Bone Joint Surg Am 53 3 (1971) 523-537
30. Sakakibara Y., Miura T., Iwata H., Kikuchi T., Yamaguchi T., Yoshimi T., et al. Effect of high-molecular-weight sodium hyaluronate on immobilized rabbit knee. Clin Orthop Relat Res 299 (1994) 282-292
31. Kenzora J.E., Steele R.E., Yosipovitch Z.H., and Glimcher M.J. Experimental osteonecrosis of the femoral head in adult rabbits. Clin Orthop 130 (1978) 8-46
32. Chavassieux P.M., Arlot M.E., Reda C., Wei L., Yates A.J., and Meunier P.J. Histomorphometric assessment of the long-term effects of alendronate on bone quality and remodeling in patients with osteoporosis. J Clin Invest 100 6 (1997) 1475-1480
33. Nagashima M., Sakai A., Uchida S., Tanaka S., Tanaka M., and Nakamura T. Bisphosphonate (YM529) delays the repair of cortical bone defect after drill-hole injury by reducing terminal differentiation of osteoblasts in the mouse femur. Bone 36 3 (2005) 502-511
34. Kenzora J.E., and Glimcher M.J. Pathogenesis of idiopathic osteonecrosis: the ubiquitous crescent sign. Orthop Clin North Am 16 4 (1985) 681-696
35. Kim H.K., and Su P.H. Development of flattening and apparent fragmentation following ischemic necrosis of the capital femoral epiphysis in a piglet model. J Bone Joint Surg Am 84-A 8 (2002) 1329-1334
36. Grynpas M.D., Alpert B., Katz I., Lieberman I., and Pritzker K.P. Subchondral bone in osteoarthritis. Calcif Tissue Int 49 1 (1991) 20-26
37. Pelletier J.P. Rationale for the use of structure-modifying drugs and agents in the treatment of osteoarthritis. Osteoarthritis Cartilage 12 Suppl A (2004) S63-S68
38. Goldring S.R., and Gravallese E.M. Bisphosphonates: environmental protection for the joint?. Arthritis Rheum 50 7 (2004) 2044-2047
39. Hayami T., Pickarski M., Wesolowski G.A., McLane J., Bone A., Destefano J., et al. The role of subchondral bone remodeling in osteoarthritis: reduction of cartilage degeneration and prevention of osteophyte formation by alendronate in the rat anterior cruciate ligament transection model. Arthritis Rheum 50 4 (2004) 1193-1206
40. Huffman K.M., Bowers J.R., Dailiana Z., Huebner J.L., Urbaniak J.R., and Kraus V.B. Synovial fluid metabolites in osteonecrosis. Rheumatology (Oxford) 46 3 (2007) 523-528
41. Kato S., Yamada H., Terada N., Masuda K., Lenz M.E., Morita M., et al. Joint biomarkers in idiopathic femoral head osteonecrosis: comparison with hip osteoarthritis. J Rheumatol 32 8 (2005) 1518-1523
42. Vannucchi A.M., Ficarra G., Antonioli E., and Bosi A. Osteonecrosis of the jaw associated with zoledronate therapy in a patient with multiple myeloma. Br J Haematol 128 6 (2005) 738
43. Migliorati C.A., Schubert M.M., Peterson D.E., and Seneda L.M. Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone: an emerging oral complication of supportive cancer therapy. Cancer 104 1 (2005) 83-93
44. Gangji V., Hauzeur J.P., Matos C., De Maertelaer V., Toungouz M., and Lambermont M. Treatment of osteonecrosis of the femoral head with implantation of autologous bone-marrow cells. A pilot study. J Bone Joint Surg Am 86-A 6 (2004) 1153-1160
45. Katsube K., Bishop A.T., Simari R.D., Yla-Herttuala S., and Friedrich P.F. Vascular endothelial growth factor (VEGF) gene transfer enhances surgical revascularization of necrotic bone. J Orthop Res 23 2 (2005) 469-474
46. Lieberman J.R., Conduah A., and Urist M.R. Treatment of osteonecrosis of the femoral head with core decompression and human bone morphogenetic protein. Clin Orthop 429 (2004) 139-145
47. Mont M.A., Jones L.C., Einhorn T.A., Hungerford D.S., and Reddi A.H. Osteonecrosis of the femoral head. Potential treatment with growth and differentiation factors. Clin Orthop Suppl 355 (1998) S314-S335
48. Nakamae A., Sunagawa T., Ishida O., Suzuki O., Yasunaga Y., Hachisuka H., et al. Acceleration of surgical angiogenesis in necrotic bone with a single injection of fibroblast growth factor-2 (FGF-2). J Orthop Res 22 3 (2004) 509-513